|
|
Article: Panel: Communication Is Key For Working With The FDA.(Conference notes)
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
MONTREAL - Getting a drug from the early stages of development to the market is no mean feat, especially for small companies, but maintaining effective communication with the FDA can keep firms from getting lost on the regulatory pathway, said a panel of industry experts at the VentureForum East conference here.
On the final day of the meeting, attendees gathered in the ballroom at the Marriott Chateau Champlain hotel for a discussion, titled "Rules of Engagement: Best Practices for Working with the FDA," a topic of particular importance for small or foreign biotech firms.
From 1996 to 2006, the number of drugs approved by the FDA ...